A-41 does not require an AOM to be from an individual with the same numerous specialties as the defending physician; instead, it requires only the same 'specialty or subspecialty' in the singular," ...
The decision to file in state or federal court, or even whether to remove a case to federal court, can be outcome determinative. One would not necessarily expect that to be the case, and perhaps some ...
Baker & Hostetler, Foley Hoag, Baker Botts, Quinn Emanuel Urquhart & Sullivan, King & Spalding and McGuireWoods announced new lateral partners in their D.C. offices over the past week.
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...
Addressing a circuit split over whether insurance solvency funds are considered a "primary plan," U.S. District Judge Robert W. Gettleman concluded the Illinois Insurance Guaranty Fund was not ...
The Georgia Supreme Court, Georgia Court of Appeals and multiple county courts have extended closures through Jan. 22 due to inclement weather forecast throughout the state.
"I also think discovery concerning the existence of, or removal of, such policies is fair game because they can be indicative ...
The partner is following in the footsteps of several of his former Goodwin colleagues who defected to Fried Frank last year.
Skadden, Latham, Kirkland and Davis Polk—traditionally the strongest legal advisers for major U.S. listings by Chinese companies—acted on fewer than five of these IPOs last year, according to a ...
As third and fourth generations take over, businesses are finding it difficult to manage the complexities of family transition without legal advisers.
As MCAs grow in popularity, there is concern about an increase in companies claiming to negotiate MCA terms on behalf of business owners. While these services may seem appealing, they come with ...
The authors write "Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., and used in the treatment of opioid dependence. In January of 2022, the FDA ...